Basic mechanisms of platelet receptor shedding

Platelets

Volumn 28, Issue 4, 2017, Pages 319-324

  Andrews, Robert K ^a,b   Gardiner, Elizabeth E ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b Australian National University   (Australia)

Author keywords

ADAM; GPIb IX V; GPVI; platelets; receptors; shedding

Indexed keywords

CALMODULIN; THROMBOCYTE RECEPTOR;

HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PLATELET REACTIVITY; PLATELET RECEPTOR SHEDDING; PRIORITY JOURNAL; REVIEW; SHEAR STRESS; SURFACE PROPERTY; METABOLISM; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION;

BLOOD PLATELETS; HUMANS; PLATELET ACTIVATION; PLATELET ADHESIVENESS;

EID: 85020852607     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537104.2016.1235690     Document Type: Review

References (74)

1. Gardiner EE, Andrews RK., Platelet receptor expression and shedding:GPIb-IX-V and GPVI. Transfusion Med Reviews 2014;28:56–60.
2. Andrews RK, Karunakaran D, Gardiner EE, Berndt MC., Platelet receptor shedding:a mechanism for downregulating platelet reactivity. Arterioscler Thromb Vasc Biol 2007;27:1511–1520.
3. Berndt MC, Karunakaran D, Gardiner EE, Andrews RK., Programmed autologous cleavage of platelet receptors. J Thromb Haemostas 2007;5(Suppl 1):212–219.
4. Gardiner EE, Karunakaran D, Shen Y, Andrews RK, Berndt MC., Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. J Thromb Haemostas 2007;5:1530–1537.
5. Gardiner EE, Arthur JF, Kahn ML, Berndt MC, Andrews RK., Regulation of platelet membrane levels of glycoprotein VI by a platelet-derived metalloproteinase. Blood 2004;104:3611–3617.
6. Stephens G, Yan Y, Jandrot-Perrus M, Villeval JL, Clemetson KJ, Phillips DR., Platelet activation induces metalloproteinase-dependent GP VI cleavage to down-regulate platelet reactivity to collagen. Blood 2005;105:186–191.
7. Al Tamimi M, Tan CW, Qiao J, Pennings GJ, Javadzadegan A, Yong ASC, Arthur JF, Davis AK, Jing J, Mu F-T, et al. Pathological shear triggers shedding of vascular receptors:a novel mechanism for downregulation of platelet glycoprotein (GP)VI in stenosed coronary vessels. Blood 2012;119:4311–4320.
8. Al Tamimi M, Arthur JF, Gardiner EE, Andrews RK., Focusing on plasma GPVI. Thromb Haemostas 2012;107:648–655.
9. Gardiner EE, Andrews RK., Plasma sGPVI:Changing levels in human disease. Thromb Res 2014;133:306–307.
10. Gardiner EE, Andrews RK., Platelet adhesion. In:Platelets in thrombotic and non-thrombotic disorders vol 2. In:P Gresele, JA Lopez, NS Kleiman, CP Page editors. New York:Springer, 2016; in press.
11. Gardiner EE, Andrews RK., Metalloproteolytic receptor shedding…platelets “acting their age”. Platelets 2016;27(6):512–518.
12. Andrews RK, Berndt MC., The glycoprotein Ib-IX-V complex. In:A, Michelson (ed). Platelets. 3rd ed. San Diego:Academic Press; 2006. 195–211.
13. Luo SZ, Mo X, Afshar-Kharghan V, Srinivasan S, López JA, Li R., Glycoprotein Ibβ forms disulfide bonds with 2 glycoprotein Ibβ subunits in the resting platelet. Blood 2007;109:603–609.
14. Moog S, Mangin P, Lenain N, Strassel C, Ravanat C, Schuhler S, Freund M, Santer M, Kahn M., Platelet glycoprotein V binds to collagen and participates in platelet adhesion and aggregation. Blood 2001;98:1038–1046.
15. Arthur JF, Matzaris M, Gardiner EE, Taylor SG, Wijeyewickrema LC, Ozaki Y, Kahn ML, Andrews RK, Berndt MC., Glycoprotein (GP)VI is associated with GPIb-IX-V on the membrane of resting and activated platelets. Thromb Haemostas 2005;93:716–723.
16. Watson SP., (2009) Platelet activation by extracellular matrix proteins in haemostasis and thrombosis. Curr Pharm Des 15:1358–1372.
17. Zahid M, Mangin P, Loyau S, Hechler B, Billiald P, Gachet C, Jandrot-Perrus M., The future of glycoprotein VI as an antithrombotic target. J Thromb Haemost 2012;10:2418–2427.
18. Ozaki Y, Suzuki-Inoue K, Inoue O., Platelet receptors activated via mulitmerization:glycoprotein VI, GPIb-IX-V, and CLEC-2. J Thromb Haemost 2013;11(Suppl 1):330–339.
19. Best D, Senis YA, Jarvis GE, Eagleton HJ, Roberts DJ, Saito T, Jung SM, Moroi M, Harrison P, Green FR, Watson SP., GPVI levels in platelets:relationship to platelet function at high shear. Blood 2003;102:2811–2818.
20. Chen H, Locke D, Liu Y, Liu C, Kahn ML., The platelet receptor GPVI mediates both adhesion and signalling responses to collagen in a receptor density-dependent fashion. J Biol Chem 2002;277:3011–3019.
21. Loyau S, Dumont B, Ollivier V, Boulaftali Y, Feldman L, Ajzenberg N, Jandrot-Perrus M., Platelet glycoprotein VI dimerization, an active process inducing receptor competence, is an indicator of platelet reactivity. Arterioscler Thromb Vasc Biol 2012;32:778–785.
22. Samaha FF, Hibbard C, Sacks J, Chen H, Varello MA, George T, Kahn ML., Density of platelet collagen receptors glycoprotein VI and α2β1 and prior myocardial infarction in human subjects, a pilot study. Med Sci Monitor 2005;11:CR224–CR229.
23. Gardiner EE, Arthur JF, Shen Y, Karunakaran D, Moore LA, Schulte Am Esch II Jr, Andrews RK, Berndt MC. GPIbα-selective activation of platelets induces platelet signalling events comparable to GPVI activation events. Platelets 2010;21:244–252.
24. Kruss S, Erpenbeck L, Amschler K, Mundinger TA, Helms H-J, Friede T, Andrews RK, Schön MP, Spatz JP., Adhesion maturation of neutrophils on nanoscopically presented platelet receptor GPIbα. ACS Nano 2013;7:9984–9996.
25. Fong KP, Barry C, Tran AN, Traxler EA, Wannemacher KM, Tang HY, Speicher KD, Blair IA, Speicher DW, Grosser T, et al. Deciphering the human platelet sheddome. Blood 2011;117:e15–e26.
26. Fox JE, Aggerbeck LP, Berndt MC., Structure of the glycoprotein Ib.IX complex from platelet membranes. J Biol Chem 1988;263:4882–4890.
27. Ramakrishnan V, DeGuzman F, Bao M, Hall SW, Leung LL, Phillips DR., A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein V. Proc Natl Acad Sci USA 2001;98:1823–1828.
28. Bender M, Hofmann S, Stegner D, Chalaris A, Bösl M, Braun A, Scheller J, Rose-John S, Nieswandt B., Differentially regulated GPVI ectodomain shedding by multiple platelet-expressed proteinases. Blood 2010;116:3347–3355.
29. Sawicki G, Sanders EJ, Salas E, Wozniak M, Rodrigo J, Radomski MW., Localization and translocation of MMP-2 during aggregation of human platelets. Thromb Haemost 1998;80:836–839.
30. Janes PW, Saha N, Barton WA, Kolev MV, Wimmer-Kleikamp SH, Nievergall E, Blobel CP, Himanen JP, Lackmann M, Nikolov DB., Adam meets Eph:an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans. Cell 2005;123:291–304.
31. Gardiner EE, Al-Tamimi M, Mu F-T, Karunakaran D, Thom JY, Moroi M, Andrews RK, Berndt MC, Baker RI., Compromised ITAM-based platelet receptor function in a patient with immune thrombocytopenic purpura. J Thromb Haemostas 2008;6:1175–1182.
32. Gardiner EE, Thom JY, Al-Tamimi M, Hughes A, Berndt MC, Andrews RK, Baker RI., Restored platelet function after romiplostim treatment in a patient with immune thrombocytopenic purpura. Br J Haematol 2010; 149:625–628.
33. Andrews RK, Munday AD, Mitchell CA, Berndt MC., Interaction of calmodulin with the cytoplasmic domain of the glycoprotein Ib-IX-V complex. Blood 2001;98:681–687.
34. Andrews RK, Suzuki-Inoue K, Shen Y, Tulasne D, Watson SP, Berndt MC., Interaction of calmodulin with the cytoplasmic domain of platelet glycoprotein VI. Blood 2002;99:4219–4221.
35. Gardiner EE, Arthur JF, Berndt MC, Andrews RK., Role of calmodulin in platelet receptor function. Curr Med Chem 2005;3:173–179.
36. Facey A, Pinar I, Arthur JF, Qiao J, Mado B, Carberry J, Andrews RK, Gardiner EE., A-Disintegrin-And-Metalloproteinase (ADAM)10 activity on resting and activated platelets. Biochemistry 2016;55:1187–1194.
37. Al-Tamimi M, Grigoriadis G, Tran H, Paul E, Servadei P, Berndt MC, Gardiner EE, Andrews RK., Coagulation-induced shedding of platelet glycoprotein VI mediated by Factor Xa. Blood 2011; 117:3912–3920.
38. Al-Tamimi M, Mu F-T, Moroi M, Gardiner EE, Berndt MC, Andrews RK., Measuring soluble platelet glycoprotein VI in human plasma by ELISA. Platelets 2009;20:143–149.
39. Mammadova-Bach E, Ollivier V, Loyau S, Schaff M, Dumont B, Favier R, Freyburger G, Latger-Cannard V, Nieswandt B, Gachet C, et al. Platelet glycoprotein VI binds to polymerized fibrin and promotes thrombin generation. Blood 2015;126:683–691.
40. Alshehri OM, Hughes CE, Montague S, Watson SK, Frampton J, Bender M, Watson SP., Fibrin activates GPVI in human and mouse platelets. Blood 2015;126:1601–1608.
41. Gardiner EE, Karunakaran D, Arthur JF, Mu F-T, Powell MS, Baker RI, Hogarth M, Kahn ML, Andrews RK, Berndt MC. Dual, ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors:De-ITAM-ising FcγRIIa. Blood 2008;111:165–174.
42. Qiao J, Al Tamimi M, Baker R, Andrews RK, Gardiner EE., The platelet Fc receptor, FcγRIIa. Immuno Rev 2015;268:241–252.
43. Bergmeier W, Piffath CL, Cheng G, Dole VS, Zhang Y, von Andrian UH, Wagner DD., Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates GPIbα shedding from platelets in vitro and in vivo. Circ Res 2004;95:677–683.
44. Schoenwaelder SM, Jarman K, Gardiner EE, Hua M, Qiao JL, White JM, Josefsson EC, Alwis I, Ono A, Willcox A, et al. Bcl-xL inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets. Blood 2011;118:1663–1674.
45. Kile BT., The role of apoptosis in megakaryocytes and platelets. Br J Haematol 2014; 165(2):217–226.
46. Schleicher RI, Reichenbach F, Kraft P, Kumar A, Lescan M, Todt F, Göbel K, Hilgendorf I, Geisler T, Bauer A, et al. Platelets induce apoptosis via membrane-bound FasL. Blood 2015;126(12):1483–1493.
47. Qiao J, Schoenwaelder SM, Mason KD, Tran H, Davis AK, Kaplan ZS, Jackson SP, Kile BT, Andrews RK, Roberts AW, et al. Low adhesion receptor levels on circulating platelets in patients with lymphoproliferative diseases before receiving Navitoclax (ABT-263). Blood 2013;121(8):1479–1481.
48. Noy PJ, Yang J, Reyat JS, Matthews AL, Charlton AE, Furmston J, Rogers DA, Rainger GE, Tomlinson MG., TspanC8 tetraspanins and a disintegrin and metalloprotease 10 (ADAM10) interact via their extracellular regions:evidence for distinct binding mechanisms for different TspanC8s. J Biol Chem 2016;291:3145–3157.
49. Matthews AL, Noy PJ, Reyat JS, Tomlinson MG., Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17:The emerging role of tetraspanins and rhomboids. Platelets 2016; in press.
50. Andrews RK, Arthur JF, Gardiner EE., Targeting GPVI as a novel antithrombotic strategy. J Blood Med 2014;5:59–68.
51. Liang X, Russell SR, Estelle S, Jones LH, Cho S, Kahn ML, Berndt MC, Bunting ST, Ware J, Li R., Specific inhibition of ectodomain shedding of glycoprotein Ibα by targeting its juxtamembrane shedding cleavage site. J Thromb Haemost 2013;11:2155–2162.
52. Arthur JF, Shen Y, Gardiner EE, Coleman L, Kenny D, Andrews RK, Berndt MC., TNF, Receptor-Associated Factor 4 (TRAF4) is a novel binding partner of glycoprotein Ib and glycoprotein VI in human platelets. J Thromb Haemostas 2011;9:163–172.
53. Arthur JF, Qiao J, Shen Y, Davis AK, Dunne E, Berndt MC, Gardiner EE, Andrews RK., ITAM receptor-mediated generation of reactive oxygen species in human platelets occurs via Syk-dependent and –independent pathways. J Thromb Haemost 2012;10:1133–1141.
54. Dunkley S, Arthur JF, Evans S, Gardiner EE, Shen Y, Andrews RK., A familial platelet function disorder associated with abnormal signalling through the glycoprotein VI pathway. Br J Haematol 2007;137:569–577.
55. Murai T, Maruyama Y, Mio K, Nishiyama H, Suga M, Sato C., Low cholesterol triggers membrane microdomain-dependent CD44 shedding and suppresses tumor cell migration. J Biol Chem 2011;286:1999–2007.
56. Rumjantseva V, Grewal PK, Wandall HH, Josefsson EC, Sorensen AL, Larson G, Marth JD, Hartwig JH, Hoffmeister KM., Dual roles for hepatic lectin receptors in the clearance of chilled platelets. Nature Med 2009;15:1273–1280.
57. Urbanus RT, van der Wal DE, Koekman CA, Huisman A, van den Heuvel DJ, Gerritsen HC, Deckmyn H, Akkerman J-WN, Schutgens, REG, Gitz E., Patient autoantibodies induce platelet destruction signals via raft-associated glycoprotein Ibα and FcgRIIa in immune thrombocytopenia. Haematologia 2013;98:e70–e72.
58. Jansen AJG, Josefsson EC, Rumjantseva V, Liu QP, Falet H, Bergmeier W, Cifuni SM, Sackstein R, von Andrian UH, Wagner DD, et al. Desialylation accelerates platelet clearance after refrigeration and initiates GPIbα metalloproteinase-mediated cleavage in mice. Blood 2012;119:1263–1273.
59. Shao L, Wu Y, Zhou H, Qin P, Ni H, Peng J, Hou M., Successful treatment with oseltamivir phosphate in a patient with chronic immune thrombocytopenia positive for anti-GPIb/IX autoantibody. Platelets 2015;26(5):495–497.
60. Alioglu B, Tasar A, Ozen C, Selver B, Dallar Y., An experience of oseltamivir phosphate (tamiflu) in a pediatric patient with chronic idiopathic thrombocytopenic purpura:a case report. Pathophysiol Haemost Thromb 2010;37:55–58.
61. Li J, van der Wal DE, Zhu G, Xu M, Yougbare I, Ma L, Vadasz B, Carrim N, Grozovsky R, Ruan M, et al. Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia. Nat Commun 2015;6:e7737.
62. Barsam SJ, Psaila B, Forestier M, Page LK, Sloane PA, Geyer JT, Villarica GO, Ruisi MM, Gernsheimer TB, Beer JH, et al. Platelet production and platelet destruction:assessing mechanisms of treatment effect in immune thrombocytopenia. Blood 2011;117(21):5723–5732.
63. Ungerer M, Rosport K, Bültmann A, Piechatzek R, Uhland K, Schlieper P, Gawaz M, Münch G., Novel antiplatelet drug revacept (Dimeric Glycoprotein VI-Fc) specifically and efficiently inhibited collagen-induced platelet aggregation without affecting general hemostasis in humans. Circulation 2011;123(17):1891–1899.
64. Goebel S, Li Z, Vogelmann J, Holthoff HP, Degen H, Hermann DM, Gawaz M, Ungerer M, Münch G., The GPVI-Fc fusion protein Revacept improves cerebral infarct volume and functional outcome in stroke. PLoS One 2013;8(7):e66960.
65. Ungerer M, Li Z, Baumgartner C, Goebel S, Vogelmann J, Holthoff HP, Gawaz M, Münch G., The GPVI-Fc fusion protein Revacept reduces thrombus formation and improves vascular dysfunction in atherosclerosis without any impact on bleeding times. PLoS One 2013;8(8):e71193.
66. Coller BS, Kalomiris E, Steinberg M, Scudder LE., Evidence that glycocalicin circulates in normal plasma. J Clin Invest 1984;73:794–799.
67. Qiao J, Shen Y, Gardiner EE, Andrews RK., Proteolysis of platelet receptors in humans and other species. Biol Chem 2010;391:893–900.
68. Bigalke B, Elvers M, Schönberger T, Gawaz M., Platelet and soluble glycoprotein VI - novel applications in diagnosis and therapy. Curr Drug Targets 2011;12(12):1821–1830.
69. Wurster T, Poetz O, Stellos K, Kremmer E, Melms A, Schuster A, Nagel E, Joos T, Gawaz M, Bigalke B., Plasma levels of soluble glycoprotein VI (sGPVI) are associated with ischemic stroke. Platelets 2013;24(7):560–565.
70. Bigalke B, Pötz O, Kremmer E, Geisler T, Seizer P, Puntmann VO, Phinikaridou A, Chiribiri A, Nagel E, Botnar RM, et al. Sandwich immunoassay for soluble glycoprotein VI in patients with symptomatic coronary artery disease. Clin Chem 2011;57(6):898–904.
71. Bigalke B, Stellos K, Weig HJ, Geisler T, Seizer P, Kremmer E, Pötz O, Joos T, May AE, Lindemann S, et al. Regulation of platelet glycoprotein VI (GPVI) surface expression and of soluble GPVI in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS). Basic Res Cardiol 2009;104:352–357.
72. Yamashita Y, Naitoh K, Wada H, Ikejiri M, Mastumoto T, Ohishi K, Hosaka Y, Nishikawa M, Katayama N., Elevated plasma levels of soluble platelet glycoprotein VI (GPVI) in patients with thrombotic microangiopathy. Thromb Res 2014;133(3):440–444.
73. Al-Tamimi M, Gardiner EE, Thom JY, Shen Y, Cooper MN, Hankey GJ, Berndt MC, Baker RI, Andrews RK., Soluble glycoprotein VI is raised in the plasma of patients with acute ischemic stroke. Stroke 2011;42(2):498–500.
74. Muthiah K, Connor D, Ly K, Gardiner EE, Andrews RK, Qiao J, Rutgers D, Robson D, Low J, Jarvis S, et al. Longitudinal changes in haemostatic parameters and reduced pulsatility contribute to non-surgical bleeding in patients with centrifugal continuous flow left ventricular assist devices. J Heart Lung Transpl 2016;35(6):743–751.